Matrix View - JPND Neurodegenerative Disease Research

Matrix View

Home » Global Cohort Portal » Matrix View

Diseases

Alzheimer's disease
Dementia (unclassified)
Frontotemporal dementia
Huntington's disease
Lewy body disease
Mild cognitive impairment (MCI)
Motor neurone disease
Other NDs not listed
Parkinson's disease
Prion disease
Spinal muscular atrophy (SMA)
Spinocerebellar ataxia (SCA)
Subjective memory complaints (SMC) or subjective cognitive decline (SCD)
Type of dementia/ND not specified
Vascular dementia

Genders

Female
Male
Male and Female

Sample sizes

0 to 4,999
10,000 to 14,999
10,000 to 19,999
100,000 to 499,999
15,000 to 19,999
20,000 to 49,999
5,000 to 9,999
50,000 to 99,999
500,000+

Ages

0 to 9
10 to 19
100+
20 to 39
40 to 59
60 to 100

Types

General population-based cohort
Neurodegenerative disease-specific cohort
Rare neurodegenerative condition

Participant Types

At-risk diagnosis
Condition diagnosed
No diagnosis

Countries

Albania
Australia
Austria
Belgian
Belgium
Brazil
Canada
Chile
China
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
India
Ireland
Israel
Italy
Japan
Luxembourg
Malaysia
Multiple Countries
Netherlands
New Zealand
Nigeria
Norway
Poland
Portugal
Romania
Singapore
Slovenia
South Africa
South Korea
Spain
Sweden
Switzerland
Thailand
Tunisia
Turkey
United Kingdom
USA

Brain related measures

Behaviour
Cognitive function
Mental health
Neurological

Funtional rating

Caregiver
Individual physiological
Individual psychological

Anthropometric

Blood pressure
Height
Hip circumference
Waist circumference
Weight

Physical

Cardiovascular
Hearing and Vision
Musculoskeletal
Reproductive
Respiratory

Biological samples

Blood
Cardiovascular
Cerebral spinal fluid (CSF)
CSF biomarker data available
Hearing and vision
If CSF was collected is biomarker data available
Microbiome
Musculoskeletal
Other
Reproductive
Respiratory
Saliva
Urine

Genotyping

Gene screening

Brain imaging

Electroencephalogram (EEG)
Magnetic resonance imaging (MRI)
Magnetic resonance spectroscopy (MRS)
Magnetoencephalography (MEG)
Positron emission tomography (PET) - amyloid
Positron emission tomography (PET) fluorine18 flurodeoxyglucose (FDG)
Single photon emission computerised tomography (SPECT)

Brain banking

Consent for brain donation

Lifestyle

Alcohol
Dietary habits
Physical activity
Smoking

Socio-economic

Education
Ethnic group
Family circumstances
Housing and accommodation
Income and employment
Income and finances
Informal support
Marital status
Martial status
Occupation and employment
Unpaid care

Health service utilisation

Formal health and social care service utilisation including private care

	Recruitment Period	Sex	Sample Size	Age
1958 National Child Development Study Compare cohort	1958	MF	15,000 to 19,999	0
The 1970 British Cohort Study Compare cohort	01/04/1970	MF	15,000 to 19,999	0
The 1982 Pelotas (Brazil) Birth Cohort Study Compare cohort	1982	MF	0 to 4,999	0
A Population Based Prospective Cohort Study to Unravel the Causes of Stroke and Cognitive Decline: A Cross-Cultural Perspective Compare cohort	2015-18	MF	10,000 to 19,999	>50
Aberdeen Birth Cohort 1921 Compare cohort	1st June 1932	MF	50,000 to 99,999	11
Aberdeen Birth Cohort 1936 Compare cohort	4th June 1947	MF	50,000 to 99,999	11
Aberdeen Children of the 1950s Compare cohort	1962	MF	10,000 to 19,999	7-12
Ageing in Women and Men: A Longitudinal Study of Gender Differences in Health Behaviour and Health among Elderly Compare cohort	1994	MF	0 to 4,999	69-88
The Airwave Health Monitoring Study Compare cohort	2004-2017	MF	50,000 to 99,999	>16
Alberta’s Tomorrow Project Compare cohort	2000-2015	MF	50,000 to 99,999	35-69